Jefferies Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-166,700
Closed -$29.6M 1564
2024
Q4
$29.6M Sell
166,700
-84,200
-34% -$15.5M 0.18% 92
2024
Q3
$49.5M Buy
+250,900
New +$46.8M 0.35% 41
2023
Q3
Sell
-12,500
Closed -$1.68M 1572
2023
Q2
$1.68M Sell
12,500
-39,000
-76% -$5.72M 0.02% 722
2023
Q1
$8.21M Buy
51,500
+6,500
+14% +$994K 0.07% 255
2022
Q4
$7.27M Buy
+45,000
New +$6.9M 0.05% 296

Other funds holding ABBV

Jefferies Financial Group's ABBV Position: Q2 2026 in Review

Jefferies Financial Group increased its AbbVie (ABBV) stake by 29% in Q2 2026, buying an estimated $12.9M and bringing the position to 268,264 shares worth $67.5M. The position accounts for 0.44% of the portfolio, ranked #33.

Jefferies Financial Group first reported a position in ABBV in Q1 2017 and has held it in 20 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Jefferies Financial Group held 268,264 shares of AbbVie worth $67.5M as of Q2 2026.
  • Jefferies Financial Group bought 59,905 AbbVie shares in Q2 2026, an estimated $12.9M.
  • AbbVie made up 0.44% of Jefferies Financial Group's portfolio in Q2 2026, its #33 holding.
  • Jefferies Financial Group first reported a position in AbbVie in Q1 2017 and has held it in 20 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.